drugset / Trial / NCT00157885
A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.
Completed
400 enrolled
Menzies School of Health Research
National Health and Medical Research Council, Australia · collabNational Institute of Health Research and Development, Ministry of Health Republic of Indonesia · collabWellcome Trust · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary aim of the comparative trial is to assess the relative safety and efficacy of two artemisinin containing regimens: amodiaquine plus artesunate (AAQ) and artekin both administered once daily for 3 days.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | — | — |
| Subject | Dihydroartemisinin-piperaquine | Unknown | — | — |
| Subject | amodiaquine | Other / unclassified | — | — |